Abstract
OBJECTIVE: Inhaled nitric oxide (iNO) improves oxygenation and reduces the need for extracorporeal membrane oxygenation in infants with severe persistent pulmonary hypertension of the newborn (PPHN). The effectiveness of iNO in the treatment of moderate PPHN has not been adequately defined. We therefore conducted a randomized, prospective multicenter study to assess whether iNO in patients with moderate PPHN would improve arterial paO2, prevent progression to severe PPHN, and improve outcomes.
METHODS: Infants ≥34 weeks gestation with moderate pulmonary hypertension (alveolar–arterial oxygen gradient (AaDO2) 500–599 Torr) were randomly assigned to continue standard medical therapy (control group) or standard medical therapy plus iNO (iNO group). For each patient in the iNO group, iNO concentration was increased in steps of 10–20 ppm every 30 minutes until there was no further improvement in arterial paO2. This concentration of iNO was then maintained while all other ventilatory support, including inspired oxygen concentration, was weaned according to a predefined protocol.
RESULTS: In all, 27 of 40 control patients (58%) compared to six of 40 infants (15%) in the iNO group failed assigned therapy and developed severe PPHN (p<0.0005). Arterial paO2 improved from 112±48 to 133±100 (p=0.132) in control infants compared to an increase from 101±29 to 208±118 (p<0.0005) in iNO-treated patients. For the first 36 hours after study, entry AaDO2 levels and ventilatory support were significantly lower in iNO-treated infants compared to control patients.
CONCLUSION: In patients with moderate PPHN, treatment with iNO improves arterial paO2, reduces the amount of ventilatory support needed, and prevents progression to severe PPHN.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Kinsella JP, Neish SR, Ivy DD, Shaffer E, Abman SH . Clinical responses to prolonged treatment of persistent pulmonary hypertension of the newborn with low doses of inhaled Nitric Oxide. J Pediatrics 1993;123(1):103–108.
Kinsella JP, Truog WE, Walsh WF, et al. Randomized, multicenter trial of inhaled Nitric Oxide and high-frequency oscillatory ventilation in severe, persistent pulmonary hypertension of the newborn. J Pediatrics 1997;131:55–62.
The Neonatal Inhaled Nitric Oxide Study Group. Inhaled Nitric Oxide in full-term and nearly full-term infants with hypoxic respiratory failure. N Engl J Medi 1997;336(9):597–604.
Clark HR, Kueser TJ, Walker MW, et al. Low-dose nitric oxide therapy for persistent pulmonary hypertension of the newborn. N Engl J Med 2000;342(7):469–474.
Christou H, Van Marter LJ, Wessel DL, et al. Inhaled Nitric Oxide reduces the need for extracorporeal membrane oxygenation in infants with persistent pulmonary hypertension of the newborn. Crit Care Med 2000;28(11):3722–3727.
Hintz SR, Suttner DM, Sheehan AM, Rhine WD, Van Meurs KP . Decreased use of neonatal extracorporeal membrane oxygenation (ECMO): how new treatment modalities have affected ECMO utilization. Pediatrics 2000;106(6):1339–1343.
Walsh-Sukys M, Tyson J, Wright L, et al. Persistent pulmonary hypertension of the newborn in the era before nitric oxide: practice variation and outcomes. Pediatrics 2000;105(1):14–20.
Davidson D, Barefield ES, Kattwinkel J, et al. Inhaled Nitric Oxide for the early treatment of persistent pulmonary hypertension of the term newborn: a randomized, double-masked, placebo-controlled, dose–response, multicenter study. Pediatrics 1998;101(3):325–334.
The Franco-Belgium NO Trial Group. Early compared with delayed iNO in moderately hypoxaemic neonates with respiratory failure: a randomised controlled trial. Lancet 1999;354:1066–1071.
Clark HR, Yoder B, Sell MS . Prospective, randomized comparision of high-frequency oscillation and conventional ventilation in candidates for extracorporeal membrane oxygenation. J Pediatrics 1994;124(3):447–454.
Gupta A, Rastogi S, Sahni R, et al. Inhaled Nitric Oxide and gentle ventilation in the treatment of pulmonary hypertension of the newborn–a single center, 5-year experience. J Perinatol 2002;22:435–441.
Finer NN, Sun JW, Rich W, Knodel E, Barrington K . Randomized, prospective study of low-dose versus high-dose Inhaled Nitric Oxide in the neonate with hypoxic respiratory failure. Pediatrics 2001;108(4):949–955.
Acknowledgements
We thank Phyllis Anderson, RRT, and Kathy Sisco, RN, who helped in data collection and entry.
Author information
Authors and Affiliations
Additional information
In addition to the authors, the following investigators and institutions participated in this study — John L. Hauver, BA, RRT, Cardinal Glennon Children's Hospital, St. Louis, MO, Al Rastogi, MD, Cook County Hospital, Vivek Ghai, MD, Illinois Masonic Medical, Chicago, IL, Marc G. Weiss, Monika Bhola, MD, Loyola Medical Center, Maywood, IL, Claudia Hart, MD, Magee Women's Hospital, Pittsburgh, PA, Minyuen Enger, MD, Michael Reese Hospital, Chicago, IL, Gary L. Dreyer, MD, St. John's Mercy Medical Center, St. Louis, MO, P. Tom Russell, The Children's Hospital of Illinois, OSF St. Francis Medical Center, Peoria, IL, Shamim Malik, MD, Diane M. Montoto, St. Francis Hospital, EOPC, Tulsa, OK, Ushanalini Vasan, MD, Rush-Presbyterian-St. Luke's Center, Chicago, IL.
Rights and permissions
About this article
Cite this article
Sadiq, H., Mantych, G., Benawra, R. et al. Inhaled Nitric Oxide in the Treatment of Moderate Persistent Pulmonary Hypertension of the Newborn: A Randomized Controlled, Multicenter Trial. J Perinatol 23, 98–103 (2003). https://doi.org/10.1038/sj.jp.7210878
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.jp.7210878
This article is cited by
-
Inhaled PGE1 in neonates with hypoxemic respiratory failure: two pilot feasibility randomized clinical trials
Trials (2014)
-
Randomized controlled trial of early compared with delayed use of inhaled nitric oxide in newborns with a moderate respiratory failure and pulmonary hypertension
Journal of Perinatology (2010)
-
Inhaled nitric oxide in the neonate
Journal of Perinatology (2009)
-
Effect of increasing doses of magnesium in experimental pulmonary hypertension after acute pulmonary embolism
Intensive Care Medicine (2004)